Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Abstract Hepatocellular carcinoma (HCC), the third cause of cancer-related deaths worldwide, continues to present significant therapeutic challenges. Despite significant therapeutic advancement in the last decade, the efficacy of systemic treatments for patients with advanced HCC remains unsatisfact...
Saved in:
| Main Authors: | Romain Desert, Fabio Gianonne, Antonio Saviano, Yujin Hoshida, Mathias Heikenwälder, Pierre Nahon, Thomas F. Baumert |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Gut and Liver |
| Online Access: | https://doi.org/10.1038/s44355-025-00018-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
by: Hiroaki Kanzaki, et al.
Published: (2025-01-01) -
Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
by: Hiroaki Kanzaki, et al.
Published: (2025-01-01) -
Molecular and immune landscape of hepatocellular carcinoma for therapeutic development
by: Hiroyuki Suzuki, et al.
Published: (2025-03-01) -
Role of Immunotherapy in the Treatment of Hepatocellular Carcinoma
by: Irina Y. Dobrosotskaya, et al.
Published: (2025-04-01) -
Future perspectives on immunotherapy for hepatocellular carcinoma
by: Landon L. Chan, et al.
Published: (2025-03-01)